New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A3251

Introduced
3/7/22  

Caption

Requires health insurers, SHBP, and SEHBP to provide coverage for medication and treatment for hepatitis C.

Companion Bills

NJ S1191

Same As Requires health insurers, SHBP, and SEHBP to provide coverage for medication and treatment for hepatitis C.

Similar Bills

NJ S1191

Requires health insurers, SHBP, and SEHBP to provide coverage for medication and treatment for hepatitis C.

NJ S301

Provides that purchase of insulin is not subject to deductible and requires health insurers to limit copayments and coinsurance for insulin.

NJ A1439

Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.

NJ A553

Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.

NJ S1614

Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.

NJ A2839

Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.

NJ A4627

Requires DOH to maintain emergency stockpile of insulin and authorizes dispensing of emergency supply of insulin to certain patients.

NJ S1820

Requires DOH to maintain emergency stockpile of insulin and authorizes dispensing of emergency supply of insulin to certain patients.